HCPLive Network

Reprogrammed Herpes Virus Blocks Neuroblastoma Stem Cells

The results of a study led by Cincinnati Children's Hospital Medical Center—in which researchers identified possible cancer stem cells for neuroblastoma in mice and then used a reprogrammed herpes virus to block tumor formation by targeting and killing the cells—add to a collection of data showing that early-stage cancer precursor cells that have stem cell-like properties may explain how some types of cancer develop, become treatment resistant, and are prone to relapse.

“The main finding of our study is that pediatric neuroblastomas seem to have a population of cells with stem-cell characteristics that we may need to target for therapy," said Timothy Cripe, MD, PhD, senior investigator and a physician/researcher, division of Hematology/Oncology. “We also show that one promising approach for targeted treatment is biological therapy, such as an engineered oncolytic virus that seeks out and kills progenitor cells that could be the seeds of cancers.”

The researchers came to these findings by growing human neuroblastoma cells in laboratory cultures that contained cells that exhibited biological properties of neural stem cells, which then generated cell colonies that divided, grew, and were capable of diverse differentiation like stem cells. These cells carried such proteins as CD133 and nestin, known biological markers for nerve stem cells, and advanced into tumor-like cells that were tumorigenic.

These tumorigenic cells—infected with the oncolytic herpes simplex virus rQNestin34.5, which carries a molecular promoter for nestin that “causes it to seek out the protein and cancerous, or precancerous, cells where nestin resides”—were injected into mice to see if neuroblastoma tumors would form. After 60 days of observation, the researchers reported that rQNestin34 “abolished tumor growth” by attacking apparent tumor-initiating cells, as no tumors formed in any of the mice.

When using cells infected with the oncolytic herpes virus called rQLuc, which doesn’t target cells containing the nestin protein, all treated mice formed tumors within 40 days.

"Targeting and hitting the cells after they are already in the mice will be another matter," said Cripe, cautioning that much more research is needed before determining if rQNestin34.5 could be used in the treatment of human patients with neuroblastoma.

For more on this story, check out the press release from Cincinnati Children's Hospital Medical Center.

More on Stem Cells, Gene Therapy, and Cancer...


Further Reading
A research team has discovered a protein critical for the growth of pancreatic cancer tumors that, when expression was blocked, prevented tumor growth in mice.
A new study has shown positive results that PRIMA-1 could potentially become a new chemotherapy treatment for progestin-accelerated human breast cancer.
Enhancing beta cell regeneration and modulating autoimmune destruction of beta cells may be the key to effective diabetes treatment.
Researchers recently conducted a follow-up study to investigate the possibility of a link between cell phone use and uveal melanoma despite no confirmed direct link between radio wave exposure and DNA damage that can lead to cancer.
Yankees' pitcher Bartolo Colon has resurrected his career with the help of a disputed therapy involving stem cell injections.
The dramatic change in healthcare delivery from private practitioner-based to managed care created a vacuum of responsibility for self care that the patient has needed to fill.
Molecular medicine is the future of cancer treatment, but also has many potential applications in endocrinology.
More Reading